Dramatic Improvement in Generalized Pustular Psoriasis With IL-36 Inhibitor
Mark Lebwohl, MD, discusses his research finding that tapinarof improves plaque psoriasis in phase 3 trials.
Press Release
Mount Sinai Researchers Discover That Topical Treatment Improves Chronic Plaque Psoriasis
Jul 15, 2020 View All Press Releases